07:00 , Jun 21, 2010 |  BC Week In Review  |  Financial News

Corridor Pharmaceuticals completes venture financing

Corridor Pharmaceuticals Inc., Baltimore, Md.   Business: Pulmonary, Cardiovascular   Date completed: 6/17/10   Type: Venture financing   Raised: $15 million   Investors: Domain Associates; Quaker BioVentures; MedImmune Ventures; NewSpring Capital; Maryland Health Care Product Development Corp.; Ben Franklin Technology...
07:00 , Jun 21, 2010 |  BioCentury  |  Finance

Friendly persuasion

Arginetix Inc. and Immune Control Inc. agreed to merge last week in a union officiated by Quaker BioVentures, which saw an opportunity to combine a pair of early-stage portfolio companies in the same space. Gary Lessing,...
00:22 , Jun 18, 2010 |  BC Extra  |  Company News

Arginetix, Immune Control merge, raise $15 million

Arginetix Inc. (Baltimore, Md.) and Immune Control Inc. (West Conshohocken, Pa.) merged to form Corridor Pharmaceuticals Inc. and raised $15 million in a series A round. The combined company is developing therapies for vascular diseases,...
08:00 , Dec 7, 2009 |  BioCentury  |  Emerging Company Profile

Another NO to PAH: Sidebar: Corporate Profile

Arginetix Inc. Baltimore, Md. Technology: Small molecule arginase inhibitors Disease focus: Cardiovascular, inflammation Clinical status: Preclinical Founded: 2007 by Gary Lessing, Dan Berkowitz and David Christianson University collaborators: University of Pennsylvania and Johns Hopkins University Corporate partners: None Number of employees: 2 Funds raised:...
07:00 , Oct 5, 2009 |  BC Week In Review  |  Financial News

Arginetix completes venture financing

Arginetix Inc., Baltimore, Md.   Business: Cardiovascular, Genitourinary   Date completed: 10/2/09   Type: Venture financing   Raised: $10.8 million   Investors: Quaker BioVentures; MedImmune Ventures; Maryland Health Care Product Development Corp.; Osage University Partners; Red Abbey Venture Partners; Acidophil...
00:29 , Oct 3, 2009 |  BC Extra  |  Financial News

Arginetix raises $10.8 million

Arginetix Inc. (Baltimore, Md.) raised $10.8 million in a series A round co-led by Quaker BioVentures and MedImmune Ventures. Additional investors included Maryland Health Care Product Development Corp.; Osage University Partners; Red Abbey; and company...